Detalhe da pesquisa
1.
Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort.
Rheumatology (Oxford)
; 61(1): 249-257, 2021 12 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-33769455
2.
Update on antimalarials and systemic lupus erythematosus.
Curr Opin Rheumatol
; 32(6): 572-582, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32890029
3.
A 62-Year-Old Woman With Fever and Exanthema.
J Clin Rheumatol
; 25(7): e106, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31577654
4.
Balancing risks and benefits in the use of hydroxychloroquine and glucocorticoids in systemic lupus erythematosus.
Expert Rev Clin Immunol
; 20(4): 359-373, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38112074
5.
Routine biomarker profile for the prediction of clinical phenotypes of adult-onset Still's disease using unsupervised clustering algorithm.
Int J Rheum Dis
; 27(4): e15143, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38576108
6.
Intravenous cyclophosphamide improves functional outcomes in interstitial lung disease related to idiopathic inflammatory myopathies.
Semin Arthritis Rheum
; 59: 152164, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36773521
7.
Burn-out syndrome in Spanish internists during the COVID-19 outbreak and associated factors: a cross-sectional survey.
BMJ Open
; 11(2): e042966, 2021 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33574150
8.
Hydroxychloroquine Retinal Toxicity and Its Association with Dosage.
J Rheumatol
; 48(1): 150, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262306